Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Device Continuously Monitors Kidney Function

By HospiMedica International staff writers
Posted on 18 Feb 2020
A continuous urine output (UO) monitor measures flow rate and volume in real time, aiding early detection of acute kidney injury (AKI) in hospitalized patients.

The Serenno Medical (Yokneam, Israel) Sentinel device is designed for continuous kidney function assessment by accurate monitoring of UO, promoting early detection of kidney damage. More...
The system automatically detects small changes in kidney function, taking the workload off the nursing staff while delivering actionable data. Sentinel works in synergy with existing catheters and collection bags, and requires only a short and simple, non-invasive installation. The device is fully functional under any patient condition or hospital environment, such as the intensive care unit (ICU) or operating room (OR).

“Urine output measurement is a key parameter to assess kidney function. However, correct urine output determination is often difficult at the bedside, and is usually only performed intermittently and manually,” explained Professor Manu Malbrain, MD, PhD, ICU Director at University Hospital Brussels (Belgium). “Moreover, the kidneys are often the first organ to stop functioning properly, therefore continuous urine output measurement would be a valuable tool in the management of critically ill, unstable patients.”

“UO is currently monitored intermittently and manually by ICU nurses. The overworked nursing staff measures a single patient once every hour, sometimes only once every two hours. It is the only parameter still measured manually in the ICU, while the monitoring of all the other vital signs is fully automatic,” said Tomer Lark, CEO of Serenno Medical. “The completely automated Serenno system offers a solution to this problem. Using our device, nurses receive dramatically more UO data and are also automatically alerted to any change in kidney function, and thus have more time to attend to their patients' needs.”

Patients in hospital wards in general and in ICUs in particular receive a wide variety of drugs and fluids as well as other interventions, some of which have a negative effect on kidney function resulting, in a high percentage developing mild to severe kidney damage that may require dialysis or a kidney transplant. This damage is irreversible by available treatments, so early detection to avoid it is critical. Accurate and high time resolution urine monitoring is clinically accepted world-wide as the best method of achieving this goal.

Related Links:
Serenno Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.